Header Logo

Connection

CHARLES MINARD to Checkpoint Kinase 1

Back to Details
This is a "connection" page, showing publications CHARLES MINARD has written about Checkpoint Kinase 1.
CHARLES MINARD
Connection Strength
0.046
Checkpoint Kinase 1
  1. A phase 1 study of prexasertib (LY2606368), a CHK1/2 inhibitor, in pediatric patients with recurrent or refractory solid tumors, including CNS tumors: A report from the Children's Oncology Group Pediatric Early Phase Clinical Trials Network (ADVL1515). Pediatr Blood Cancer. 2021 09; 68(9):e29065.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.